Dihexa 60mg — Vial Spec, Reconstitution Math & COA

Dihexa 60mg Research Specification & Target Assay Applications

A 60mg vial of Dihexa (N-hexanoic-Tyr-Ile-6-aminohexanoic amide) contains a high-yield lyophilized mass engineered for high-throughput in vitro testing, multi-plate cell culture assays, and extended preclinical study series. Because Dihexa exhibits high potency in binding the hepatocyte growth factor (HGF) and its receptor c-Met in experimental models, laboratory protocols frequently demand precise stock concentrations to maintain consistent micromolar or nanomolar working dilutions across repeated runs.

The 60mg packaging specification is designed for research laboratories seeking to reduce intra-lot variation by preparing a centralized stock solution that can be aliquoted, frozen, and utilized across multi-week assay windows. If PX1 Research currently features alternative solid-state unit sizes or solid oral research formats such as Dihexa Capsules 10mg alongside our core catalog of all peptides, bulk high-mass vials (such as 60mg) serve specialized automated pipetting and large-scale bioassay setups. Researchers should cross-reference catalog availability with project-specific volumetric demands to select the optimal unit mass.

Reconstitution Mathematics & Volumetric Concentration Calculations

Calculating accurate working concentrations from a high-mass vial requires careful volumetric planning, especially given the hydrophobic structural characteristics of Dihexa compared to highly hydrophilic peptide salts. When reconstituting a 60mg lyophilized cake, total diluent volume determines both the molar concentration and the viscosity of the stock solution.

To achieve a 60 mg/mL stock concentration, add exactly 1.0 mL of solvent to the 60mg vial. At this concentration, every 1.0 µL of volumetric transfer yields 60 µg of active research compound (60 µg/µL). This high concentration is ideal for low-volume automated liquid handlers, though complete dissolution may require specialized co-solvent steps.

To achieve a 30 mg/mL stock concentration, add exactly 2.0 mL of solvent to the 60mg vial. This yields a working concentration of 30 µg/µL (0.03 mg/µL), providing a broader pipetting margin for manual micro-pipettes without risking volumetric drift during rapid assay setup.

To achieve a 20 mg/mL stock concentration, add exactly 3.0 mL of solvent to the 60mg vial. This yields 20 µg/µL (0.02 mg/µL), establishing a lower-viscosity solution that disperses readily into cell culture media or balanced salt solutions. For rapid automated calculations across non-standard reconstitution volumes, researchers can utilize the PX1 reconstitution calculator.

Solubility Dynamics and Solvent Selection in Laboratory Media

Unlike standard hydrophilic linear oligopeptides, Dihexa possesses an oligopeptidomimetic structure featuring hydrophobic hexanoyl and aliphatic side-chain moieties. Consequently, direct reconstitution into pure sterile water or standard phosphate-buffered saline (PBS) at high concentrations (e.g., 60 mg/mL) often results in incomplete dissolution or precipitation.

To achieve complete solubilization at 60mg per vial, laboratory protocols typically employ a primary non-aqueous solvent, such as research-grade dimethyl sulfoxide (DMSO) or ethanol, prior to downstream dilution into aqueous assay buffers. A common protocol involves initial dissolution in pure DMSO to establish a 100x or 1000x stock, followed by serial dilution into serum-free culture medium.

Researchers must ensure that the final concentration of organic solvent in cell culture assays remains below cellular toxicity thresholds (typically <0.1% v/v DMSO in cellular models). Proper temperature control (18–22°C) during initial solvent contact aids dissolution without accelerating thermal degradation.

Analytical Verification: HPLC, Mass Spectrometry, and COA Standards

High-throughput molecular assays require strict batch consistency and confirmed identity. Every batch of Dihexa distributed by PX1 Research undergoes rigorous testing in ISO 17025 accredited analytical facilities to verify structural integrity, chemical purity, and freedom from manufacturing contaminants.

High-Performance Liquid Chromatography (HPLC) is conducted on every lot to confirm a purity threshold exceeding 98.0%. The resulting chromatogram verifies the absence of truncated synthesis byproducts or organic impurities. Simultaneously, Liquid Chromatography-Mass Spectrometry (LC-MS) confirms the exact molecular mass matching the theoretical identity of Dihexa (C27H44N4O5, MW ~504.66 g/mol).

Furthermore, bacterial endotoxin testing (LAL assay) confirms that endotoxin levels remain below strict threshold limits (<0.05 EU/mg), ensuring compatibility with sensitive primary cell cultures and organoid models. Researchers can independently inspect, download, and verify lot-matched analytical documentation directly via the PX1 COA hub.

Comparative Analysis: Dihexa and Parallel Neurogenic Research Peptides

In preclinical neurobiology and synaptogenesis research, Dihexa is frequently evaluated alongside other synthetic peptides targeting cognitive processing pathways, neuroprotection, and trophic factor modulation. Understanding structural and functional distinctions helps principal investigators select the correct research candidate for specific bioassays.

When designing comparative in vitro trials, investigators often contrast Dihexa with classic regulatory peptides such as Semax 30mg and Selank 30mg, or stabilized analogs like N-Acetyl Semax Amidate. While Semax and Selank act predominantly via melanocortin receptor modulation, brain-derived neurotrophic factor (BDNF) expression, and monoaminergic system regulation, Dihexa operates via direct high-affinity binding to HGF, facilitating c-Met receptor dimerization and downstream spinogenesis.

Because Dihexa functions as an HGF mimetic rather than a traditional neuropeptide agonist, its molar potency in dendritic spine formation assays in hippocampal neuronal cultures often differs significantly from ACTH-derived molecules. Combining these distinct compound classes within comparative study arms allows researchers to map overlapping versus distinct trophic signaling cascades.

Aliquot Planning and Storage Stability Protocols

Maintaining long-term stability of a 60mg reconstituted stock solution is critical to preventing degradation, hydrolysis, or aggregation. Repeat freeze-thaw cycles compromise compound integrity and introduce volumetric errors through condensation.

Upon full reconstitution in an appropriate solvent system, the stock solution should immediately be divided into single-use micro-aliquots (e.g., 50 µL to 100 µL) in sterile, polypropylene microcentrifuge tubes. Polypropylene or low-binding fluoropolymer tubes are recommended to minimize non-specific compound absorption to tube walls.

Lyophilized vials must be stored at -20°C or -80°C prior to reconstitution, protected from direct light exposure. Once reconstituted, organic stock solutions stored at -80°C retain chemical stability for extended research windows, whereas working aqueous dilutions should be prepared fresh immediately prior to experimental incubation.

Selecting Unit Mass: 60mg Vials vs. Alternative Research Formulations

Choosing between a single large 60mg vial, multiple smaller lyophilized vials (e.g., 5mg or 10mg), or pre-formulated capsules depends entirely on the operational layout of the research laboratory.

A 60mg vial is optimal for automated robotics platforms, multi-plate screening assays, or core facilities running high-volume parallel studies where a single stock solution eliminates inter-vial reconstitution variance. Conversely, laboratories running sporadic, low-volume assays may prefer smaller unit masses to avoid long-term freezer storage of reconstituted solutions.

For non-liquid, solid-phase experimental designs or oral bioavailability models in preclinical research, pre-measured unit formats such as Dihexa Capsules 10mg provide standardized mass units without requiring liquid handling equipment. Laboratories exploring high-throughput supply agreements or custom mass allocations can consult the PX1 wholesale portal for institutional support.

Preclinical Literature & HGF/c-Met Molecular Signaling Cascade

Scientific literature surrounding Dihexa focuses primarily on its activity as a small-molecule mimetic of Hepatocyte Growth Factor (HGF). Preclinical studies suggest that Dihexa binds to HGF with high affinity, stabilizing its bioactive conformation and facilitating binding to the c-Met receptor tyrosine kinase.

In vitro data indicate that activation of the HGF/c-Met axis by Dihexa induces receptor autophosphorylation, downstream activation of the MAPK/ERK and PI3K/Akt signaling cascades, and subsequent promotion of spinogenesis and synaptogenesis in cultured primary hippocampal neurons. Animal study models examining neurodegenerative and cognitive impairment paradigms have reported robust synaptic focal rebuilding and enhanced dendritic spine density following compound administration.

All published data regarding Dihexa stem strictly from preclinical animal models and in vitro cell culture systems. It has not been approved for human or clinical applications, and research must remain confined to qualified laboratory environments exploring cell signaling, structural neurobiology, and receptor binding kinetics.

Laboratory Handling, Safety Compliance, and Disposal Rules

As a potent research compound, Dihexa must be handled exclusively by trained laboratory personnel adhering to standard Biosafety Level 1 (BSL-1) or BSL-2 practices, depending on host cell line requirements.

Personal protective equipment (PPE)—including nitrile gloves, lab coats, and safety eyewear—must be worn at all times during weighing, reconstitution, and liquid transfer. Aerosol-generation steps (such as vigorous vortexing) should be carried out inside a certified chemical fume hood or biosafety cabinet.

Disposal of unused material, reconstituted solutions, and contaminated consumables must comply with federal, state, and institutional hazardous chemical waste regulations. Waste streams containing organic solvents like DMSO must be segregated from standard aqueous waste for appropriate incineration. Review the full scientific database in the PX1 research hub for safety profiles and technical documentation.